Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase EARLY_PHASE1 1Phase 2 1Phase 1/2 1

Status

Unknown 2Withdrawn 1Recruiting 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Tumor-Agnostic 4

Conditions

Neoplasms 4Tumor Positron-Emission Tomography 1Rectal Neoplasms 1Neuroendocrine Tumors 1Mouth Neoplasms 1Lung Neoplasms 1Carcinoma, Adenoid Cystic 1Breast Neoplasms 1177Lu-EB-FAPI 1

Interventions

pembrolizumab 185Gemcitabine 170Paclitaxel 152Carboplatin 137Bevacizumab 128Surveys and Questionnaires 118Cisplatin 115Docetaxel 114Blood Specimen Collection 110Cyclophosphamide 109Exercise 108Nivolumab 98Fluorouracil 90Capecitabine 86Dexamethasone 81Radiotherapy 80Irinotecan 74Standard of Care 69Pemetrexed 68Oxaliplatin 68Leucovorin 64Drug Therapy 64Cetuximab 60Erlotinib Hydrochloride 56Sorafenib 53atezolizumab 52Ipilimumab 51Doxorubicin 50trametinib 47Interviews as Topic 47

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Neoplasms × 68Ga-FAPI × Clear all
NCT05034146 2025-06-05

68Ga-FAPI PET/CT in Malignant Tumors

Zhongnan Hospital

Phase NA Recruiting
500 enrolled
Tumor-Agnostic

Neoplasms

NCT04023240 2024-08-12

68-Ga-FAPI PET Imaging in Malignancy

Stanford University

Phase 2 Withdrawn
Tumor-Agnostic

Neoplasms

NCT05506566 2023-09-21

68Ga-FAP-CHX PET/CT : Dosimetry and Preliminary Clinical Translational Studies

First Affiliated Hospital of Fujian Medical University

Phase 1/2 Unknown
50 enrolled
Tumor-Agnostic

Neoplasms

NCT05691894 2023-01-20

Tracer Targeting FAP PET Imaging in Patients

Affiliated Hospital of Jiangnan University

Phase EARLY_PHASE1 Unknown
20 enrolled
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡